SpeeDx RNA/DNA Ratio Method Shows Promise for Bacterial Viability, Susceptibility Testing
Branded InSignia, the patented technology will first be incorporated into a gonorrhea antimicrobial susceptibility assay, followed by a point-of-care test.
Source: genomeweb.com